Project Grant R56NS148323
- Federal Project Grant Award Summary Baylor College of Medicine received a $100,228 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded September 30, 2026, with completion targeted for February 14, 2029. The award funds research into advanced neurostimulation approaches for drug-resistant epilepsy through development of the Inception Loops...
- Federal Project Grant Award Summary Emory University received a $420,142 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective May 4, 2026, through April 30, 2028. This research initiative investigates the role of extracellular vesicles (EVs)—small membranous particles released by cells—in epileptogenesis within two distinct epilepsy...
- Federal Project Grant Award Summary New York University received a $247,994 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective March 1, 2026 through April 30, 2031. Under this award, Dr. Andrew Michalak and his research team at NYU Grossman School of Medicine will conduct research to identify neural mechanisms underlying ictal onset...
- Federal Grant Award Summary Vanderbilt University Medical Center received a $545,319 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded August 15, 2025, with completion targeted for July 31, 2030. The Sahel Epilepsy Epidemiology and Genomics Study (SEEG) delivers epidemiological and genetic research services to address critical gaps in epilepsy...
- Federal Grant Award Summary The University of Virginia received a $188,237 Project Grant award dated August 5, 2025, from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds the Epilepsy Training Program (ETP), which will deliver comprehensive training and educational services to develop the next generation of epilepsy researchers through August 30,...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $236,250 to the University of California, Los Angeles through its Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) on February 3, 2026, with a completion date of January 31, 2028. This Project Grant supports fundamental neuroscience research investigating behavioral time-scale plasticity (BTSP) deficits in temporal lobe epilepsy (TLE), the most...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $1,042,170 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective September 1, 2025 through August 31, 2033. The award supports computational neuroscience research focused on model-based analysis of brain stimulation and recording...
- Grant Award Summary The Epilepsy Foundation of America received a $248,832 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective September 15, 2025, with completion targeted for June 30, 2027. This planning grant supports the development of research infrastructure and community partnerships to address health disparities in epilepsy care and...
- Federal Grant Award Summary Vanderbilt University received a $197,600 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective September 30, 2025, with completion expected by May 31, 2027. This research award supports an investigation into the neural mechanisms underlying cardiorespiratory dysfunction in temporal lobe epilepsy (TLE) and its...
- Federal Grant Award Summary The University of Alabama at Birmingham received a $237,870 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective June 1, 2026, through May 31, 2031. This research project addresses the clinical challenge of localizing seizure onset zones in drug-resistant epilepsy patients who are candidates for surgical...
Duke University's Comprehensive Epilepsy Center received a $555,895 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective July 1, 2026 through June 30, 2027. The award funds research investigating the biophysical mechanisms of temporal interference (TI) stimulation, an emerging non-invasive neuromodulation technique for treating drug-resistant epilepsy. The research will leverage stereo-electroencephalography (SEEG), macroscale scalp electroencephalography (EEG), and research microwire EEG recordings to map the spatial and temporal effects of TI stimulation on epileptic biomarkers and compare TI efficacy to direct subthreshold stimulation at both macro and microscales. This project addresses critical gaps in understanding how non-invasive TI stimulation works at the neuronal level, where it should be applied for maximum effectiveness, and under which brain states it performs optimally. The research outcomes are expected to advance the development of safer, more accessible, and cost-effective neuromodulation treatments for millions of epilepsy patients currently limited by surgical implantation requirements of existing FDA-approved systems, thereby supporting NINDS's mission to reduce the burden of neurological disease.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $555.9k | 6/30/26 |